475 related articles for article (PubMed ID: 22243802)
1. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
[TBL] [Abstract][Full Text] [Related]
2. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery.
Chuang EY; Lin KJ; Su FY; Chen HL; Maiti B; Ho YC; Yen TC; Panda N; Sung HW
J Control Release; 2013 Aug; 169(3):296-305. PubMed ID: 23195534
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW
Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787
[TBL] [Abstract][Full Text] [Related]
4. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
Su FY; Chuang EY; Lin PY; Chou YC; Chen CT; Mi FL; Wey SP; Yen TC; Lin KJ; Sung HW
Biomaterials; 2014 Apr; 35(11):3641-9. PubMed ID: 24477192
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
10. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins.
Sonaje K; Lin KJ; Tseng MT; Wey SP; Su FY; Chuang EY; Hsu CW; Chen CT; Sung HW
Biomaterials; 2011 Nov; 32(33):8712-21. PubMed ID: 21862121
[TBL] [Abstract][Full Text] [Related]
11. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Nguyen HN; Wey SP; Juang JH; Sonaje K; Ho YC; Chuang EY; Hsu CW; Yen TC; Lin KJ; Sung HW
Biomaterials; 2011 Apr; 32(10):2673-82. PubMed ID: 21256586
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
13. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.
Sonaje K; Chen YJ; Chen HL; Wey SP; Juang JH; Nguyen HN; Hsu CW; Lin KJ; Sung HW
Biomaterials; 2010 Apr; 31(12):3384-94. PubMed ID: 20149435
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
15. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
16. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
17. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
18. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
Sonaje K; Lin YH; Juang JH; Wey SP; Chen CT; Sung HW
Biomaterials; 2009 Apr; 30(12):2329-39. PubMed ID: 19176244
[TBL] [Abstract][Full Text] [Related]
20. Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation.
Mi FL; Wu YY; Lin YH; Sonaje K; Ho YC; Chen CT; Juang JH; Sung HW
Bioconjug Chem; 2008 Jun; 19(6):1248-55. PubMed ID: 18517235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
